Durkin Brian L 4
4 · AbbVie Inc. · Filed Mar 11, 2022
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Durkin Brian L
VP, Controller
Transactions
- Sale
Common Stock, $0.01 par value
2022-03-09$150.00/sh−6,946$1,041,906→ 19,094 total - Exercise/Conversion
Common Stock, $0.01 par value
2022-03-09$79.02/sh+11,682$923,112→ 37,722 total - Exercise/Conversion
Option (Right to Buy)
2022-03-09$79.02/sh−11,682$923,112→ 0 totalExercise: $79.02From: 2020-02-21Exp: 2029-02-20→ Common Stock (11,682 underlying) - Sale
Common Stock, $0.01 par value
2022-03-09$150.01/sh−11,682$1,752,396→ 26,040 total
Footnotes (3)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.04 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.03 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.